At the Intersection of Health, Health Care and Policy
Cite this article as:
Henry G. Grabowski, Joseph A. DiMasi and Genia Long
The Roles Of Patents And Research And Development Incentives In
Biopharmaceutical Innovation
Health Affairs, 34, no.2 (2015):302-310 doi: 10.1377/hlthaff.2014.1047

The online version of this article, along with updated information and services, is available at: http://content.healthaffairs.org/content/34/2/302.full.html For Reprints, Links & Permissions: http://healthaffairs.org/1340_reprints.php E-mail Alerts : http://content.healthaffairs.org/subscriptions/etoc.dtl
To Subscribe: http://content.healthaffairs.org/subscriptions/online.shtml

Health Affairs is published monthly by Project HOPE at 7500 Old Georgetown Road, Suite 600,
Bethesda, MD 20814-6133. Copyright © 2015 by Project HOPE - The People-to-People Health
Foundation. As provided by United States copyright law (Title 17, U.S. Code), no part of Health
Affairs may be reproduced, displayed, or transmitted in any form or by any means, electronic or mechanical, including photocopying or by information storage or retrieval systems, without prior written permission from the Publisher. All rights reserved.

Not for commercial use or unauthorized distribution
Downloaded from content.healthaffairs.org by Health Affairs on February 29, 2016 at UNIV OF CALIFORNIA

Intellectual Property

&

Innovation

By Henry G. Grabowski, Joseph A. DiMasi, and Genia Long
10.1377/hlthaff.2014.1047
HEALTH AFFAIRS 34,
NO. 2 (2015): 302–310
©2015 Project HOPE—
The People-to-People Health
Foundation, Inc.

doi:

Henry G. Grabowski (grabow@ econ.duke.edu) is a professor of economics at Duke
University, in Durham, North
Carolina.
Joseph A. DiMasi is director of economic analysis at the
Tufts Center for the Study of
Drug Development, Tufts
University, in